N@N

Joseph Schwartz Maintained (SPRB) at Hold with Decreased Target to $3 on, Mar 16th, 2022

Joseph Schwartz of SVB Leerink, Maintained "Spruce Biosciences, Inc." (SPRB) at Hold with Decreased Target from $5 to $3 on, Mar 16th, 2022.

Joseph has made no other calls on SPRB in the last 4 months.

There are 6 other peers that have a rating on SPRB. Out of the 6 peers that are also analyzing SPRB, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Ritu Baral of "Cowen & Co." Downgraded from Buy to Hold on, Tuesday, November 23rd, 2021

These are the ratings of the 5 analyists that currently disagree with Joseph

---

• Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $9 on, Tuesday, March 15th, 2022
• Aydin Huseynov of "Ladenburg Thalmann" Initiated at Strong Buy and Held Target at $6 on, Tuesday, March 8th, 2022
• Hartaj Singh of "Oppenheimer" Initiated at Buy and Held Target at $15 on, Friday, December 17th, 2021
• Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $6 on, Tuesday, November 16th, 2021
• Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, November 16th, 2021

Contributing Sources

---